Analyses by the FDA and others have consistently reported that unregulated CBD products are of variable purity and may contain adulterants. The post FDA: No Regulations on OTC CBD Products Forthcoming appeared first on NORML.

Analyses by the FDA and others have consistently reported that unregulated CBD products are of variable purity and may contain adulterants.

The post FDA: No Regulations on OTC CBD Products Forthcoming appeared first on NORML.

Read MoreNews Releases – NORML
%d bloggers like this: